We produce lightly powdered industrial gloves and disposable cold packs. We intend to expand our manufacturing facilities in 2023 to produce latex medical exam gloves and surgical gloves and different varieties of thermal packs (reusable cold packs, reusable heat packs and disposable cold packs) as well as latex rubber condoms and maternity pads. In the future, we plan to manufacture scalpel blades, syringes and razor blades, as well as hospital beds and medical textiles.
Our manufacturing facility is located in Eufaula, Alabama. The Eufaula facility has direct rail access to the ports of Savannah, Georgia and Mobile, Alabama.
The primary raw material used in our production process for disposable latex gloves and other latex products is raw natural rubber latex. We purchase such material from third-party brokers operating out of the Port of Savannah, which is the site of a major rubber and latex terminal.
The primary raw materials used in our production process of thermal packs are two-ply laminated polyethylene, magnesium sulphate (for hot packs), and urea, an agricultural grade fertilizer (for cold packs). These materials are purchased from suppliers and commodities chemical brokers located in the United States and shipped to our Eufaula facility via truck. Once we have increased production to full scale, we expect to have the capability to receive shipments by rail, utilizing our private, onsite rail spur.
With respect to the additional products we plan to put into production in 2023, in order to reach this production goal, we will need to obtain additional capital and complete the refurbishment and installation of certain machinery and equipment that we own. We currently have machinery in place to produce different varieties of thermal packs, including reusable cold packs, disposable heat packs, and reusable heat packs. This machinery is substantially identical to the machinery currently producing disposable cold packs, and we are in the process of refurbishing such machinery to begin production. We also have machinery onsite to manufacture maternity pads, scalpel blades, syringes and razor blades. We have contracted mechanical, electrical, and control engineers and are in discussions with original equipment manufacturers to procure installation of such machinery.
Our immediate focus is on the United States and other North American markets. Our target customers are primarily distributors and wholesalers, with a secondary focus on end users.
**Note: We are a development-stage company that has produced limited revenue to date. Net loss is for the 12 months that ended Sept. 30, 2022.
From the prospectus:
“As of September 1, 2022, we have engaged 58 full-time service providers through a third-party staffing agency. Such service providers are directly employed by the third-party staffing agency, and not by us. We estimate that, once fully operational, the factory will employ approximately 280 persons. We estimate that we will reach this employment capacity in approximately two years following this offering.”
(Note: Medical Industries of the Americas filed its S-1 on Feb. 14, 2023.)